TARO PHARMACEUTICALS CANADA
Irina Bezverbnaya is an experienced Quality Assurance professional with a strong background in the pharmaceutical and cosmetics industries. Currently serving as QA Manager for Documentation & Change Control Programs at Taro Pharmaceuticals Canada, Irina has previously held key positions at Dalton Pharma Services, including Quality Assurance Supervisor and Quality Assurance Team Leader (Compliance), where responsibilities included supervising QA teams, facilitating compliance with GMP and regulatory requirements, and overseeing internal audit programs. Irina's career also encompasses roles in quality assurance and microbiology at Apollo Health and Beauty Care, QCL-Quality Compliance Laboratories, and Furlani Foods, in addition to academic research in environmental microbiology. Education includes a Ph.D. from Far Eastern Federal University and various certificates in Pharmaceutical Regulatory Affairs and Quality Operations. Advanced training in PCR and microbiological techniques further complements Irina's expertise.
This person is not in any teams
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.